CMTA Headlines:

Gilles Bouchard

Interim CEO Predicts Banner Year in Fight Against CMT

Dear CMTA Friends: As interim CEO of the CMTA, I start this New Year with a profound sense of hope and excitement. The CMTA continues to make great progress on all fronts, and across the majority of CMT types. Now that the goal line is in sight, though, we must double down and accelerate our efforts. In this context, I am excited to share a few announcements about developments that will strengthen our organization as we go forward. Read full letter.

CMTeen, Volume1, Issue4

CMTeen Magazine: Our Special Camp Footprint Issue Is Online Now!

CMTeen is a quarterly online magazine by, for and about the 13- to 19-year-old members of the CMT community. This special issue highlights the events and stories from CMTA Camp Footprint 2016. Read it now!

Stand to End CMT

Stand to End CMT: Join the Movement

Julianna Snow, age five, passed away this summer from CMT. She was a huge inspiration for Stand to End CMT, a movement created to raise funds for treatment, and ultimately a cure, for CMT.

What is CMT?

Charcot-Marie-Tooth, or CMT, is the most commonly inherited peripheral neuropathy and affects an estimated 2.8 million people.

Find Your Local Branch

The CMTA has over 80 Branches across North America to support people with CMT, raise awareness, and fund research. Connect with your nearest Branch today!

Fundraise to End CMT

Without fundraising and community volunteers, the CMTA would not be the leading force in CMT Research that it is today. Are you ready to make an impact?

Shop Our Store

Visit our store to see some of the most fun and fashionable ways to raise awareness!

The CMTA’s STAR (Strategy to Accelerate Research)

STAR Research
The CMTA’s vision is a world where patients with CMT neuropathies have therapies available to them to manage or modify their disease. That vision is poised to become reality as STAR pushes the research forward at an ever-increasing speed.

STAR – Disease Project Team Updates

The CMTA’s research is done in teams consisting of academic labs and clinical centers sponsored by the CMTA (STAR members), working together and with alliance partners in consortium team efforts. STAR Teams are sponsored by the CMTA via a rapid process of expert review, following invitation of proposals for targeted translational efforts. All sponsorship aims to directly aid the advancement of CMT therapies.
Charity Navigator